Editorial: work and activity impairment are important considerations to optimise treatment plans for irritable bowel syndrome

Article Gastroenterology & Hepatology

Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis

Eric D. Shah et al.

Summary: This study assessed the cost-benefit of treatments for IBS with diarrhea from insurer and patient perspectives, finding that prescription drugs and neuro-modulators were preferred by patients due to reduced lost wages and out-of-pocket costs. Costs were critical determinants of treatment value, with divergent cost drivers explaining misalignment between patient and insurer preferences.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

2021 National Survey on Prior Authorization Burden and Its Impact on Gastroenterology Practice

Eric D. Shah et al.

Summary: Prior authorizations (PAs) are intended to control prescription drug expenditures but have imposed a significant burden on physicians and patients. More than half of the PA requests are related to prescription refills, resulting in physicians frequently choosing suboptimal treatments. Additionally, half of the respondents reported patients experiencing serious adverse events due to care delays caused by PAs.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living

Vivek C. Goodoory et al.

Summary: This study aimed to analyze the impact of irritable bowel syndrome (IBS) on work and activities of daily living. The study found that patients experienced significant impairment in both work and various daily activities. Severe IBS, anxiety, depression, and other factors were associated with these impairments.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Contrasting Clinician and Insurer Perspectives to Managing Irritable Bowel Syndrome: Multilevel Modeling Analysis

Eric D. Shah et al.

Summary: From the perspective of insurers, it is cost-effective to implement routine and algorithmic prescription drug coverage restrictions that require patients to first fail low-cost behavioral, dietary, and off-label treatments. These findings suggest the importance of addressing insurance coverage and drug pricing to provide optimal care for patients with IBS.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Gastroenterology & Hepatology

Abdominal Pain and Depression, Not Bowel Habits, Predict Health Care Utilization in Patients With Functional Bowel Disorders

Vanessa Yu et al.

Summary: Severity of abdominal pain and depressive symptoms are primary drivers of increased care-seeking behavior in patients with IBS, FC, and FDr. Altered bowel habits were not consistent predictors of health care utilization.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Editorial Material Gastroenterology & Hepatology